VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome

(2012) Paulina M. Wojnarowicz et al.   PLoS One

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity

(2012) P Wojnarowicz et al.   Oncogenesis

Homozygous microdeletion of the POU1F1, CHMP2B, and VGLL3 genes in chromosome 3-A novel syndrome

(2011) Galia Gat-Yablonski et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

The ESCRT Pathway

(2011) William M. Henne et al.   DEVELOPMENTAL CELL

Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor

(2011) Cristina R. Antonescu et al.   GENES CHROMOSOMES & CANCER

A continuum model for tumour suppression

(2011) Alice H. Berger et al.   NATURE

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Canonical and non-canonical autophagy: variations on a common theme of self-eating?

(2011) Patrice Codogno et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours

(2011) Ashley H. Birch et al.   PLoS One

Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells

(2010) Nathan J Bowen et al.   BMC Medical Genomics

YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas

(2010) Zofia Hélias-Rodzewicz et al.   GENES CHROMOSOMES & CANCER

The Fallopian Tube

(2010) Shannon Salvador et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Identification of novel epithelial ovarian cancer biomarkers by cross-laboratory microarray analysis

(2010) Xuefeng Jiang et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

(2010) Ahmed Ashour Ahmed et al.   JOURNAL OF PATHOLOGY

Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions

(2009) Karolin H Hallor et al.   JOURNAL OF PATHOLOGY

The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles

(2009) Michael CJ Quinn et al.   Journal of Translational Medicine

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

(2009) Celestine S Tung et al.   MODERN PATHOLOGY

Characterization of the 3p12.3-pcenregion associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer

(2009) Neal A.L. Cody et al.   MOLECULAR CARCINOGENESIS

Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer

(2009) Michael C.J. Quinn et al.   MOLECULAR CARCINOGENESIS

A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells

(2009) Eric Campeau et al.   PLoS One

Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors

(2008) M. S. Anglesio et al.   MOLECULAR CANCER RESEARCH

Large-scale genomic analysis of ovarian carcinomas

(2008) Kylie L. Gorringe et al.   Molecular Oncology